Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line
- PMID: 19266166
- DOI: 10.1007/s11010-009-0077-6
Characterization of the ATP-binding cassette transporter gene expression profile in Y79: a retinoblastoma cell line
Abstract
Chemotherapy failure was reported in treatment of retinoblastoma suggesting a role for ATP-binding cassette (ABC) proteins. Little is known about the expression pattern of ABC proteins in this cancer type. We investigated the gene expression profile of 47 ABC proteins in the human retinoblastoma cell line Y79 by TaqMan low-density array. Analysis revealed 31 ABC transporter genes expressed in this tumor cell line. Y79 cells demonstrate high gene expression of ABCA7, ABCA12, ABCB7, ABCB10, ABCC1, ABCC4, ABCD3, ABCE1, ABCF1, ABCF2, and ABCF3 (more than twofold compared to pooled RNA from different tissues). Moreover, we show that Y79 cells exhibit an active calcein efflux pointing to multidrug resistance protein (MRP)-like transporter activity. In summary, we present for the first time an ABC transporter gene expression profile in cells derived from retinoblastoma. Most of the highly expressed ABC transporter genes are typical markers of cancer cells and might exhibit potential targets for medical treatment of retinoblastoma.
Similar articles
-
Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.Melanoma Res. 2007 Oct;17(5):265-73. doi: 10.1097/CMR.0b013e3282a7e0b9. Melanoma Res. 2007. PMID: 17885581
-
Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells.Biol Pharm Bull. 2010;33(3):504-11. doi: 10.1248/bpb.33.504. Biol Pharm Bull. 2010. PMID: 20190417
-
Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses.Cancer Med. 2019 Feb;8(2):606-616. doi: 10.1002/cam4.1964. Epub 2019 Jan 22. Cancer Med. 2019. PMID: 30672151 Free PMC article.
-
Multidrug resistance: molecular mechanisms and clinical relevance.Cancer Chemother Pharmacol. 1997;40 Suppl:S3-8. doi: 10.1007/s002800051053. Cancer Chemother Pharmacol. 1997. PMID: 9272126 Review.
-
Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.Curr Med Chem. 2006;13(16):1859-76. doi: 10.2174/092986706777585077. Curr Med Chem. 2006. PMID: 16842198 Review.
Cited by
-
ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer.Onco Targets Ther. 2014 Feb 21;7:343-51. doi: 10.2147/OTT.S56029. eCollection 2014. Onco Targets Ther. 2014. PMID: 24591841 Free PMC article.
-
Global regulation via modulation of ribosome pausing by the ABC-F protein EttA.Nat Commun. 2024 Jul 26;15(1):6314. doi: 10.1038/s41467-024-50627-z. Nat Commun. 2024. PMID: 39060293 Free PMC article.
-
Identifying Genes Associated with the Anticancer Activity of a Fluorinated Chalcone in Triple-Negative Breast Cancer Cells Using Bioinformatics Tools.Int J Mol Sci. 2025 Apr 12;26(8):3662. doi: 10.3390/ijms26083662. Int J Mol Sci. 2025. PMID: 40332279 Free PMC article.
-
Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):14. doi: 10.1167/iovs.65.14.14. Invest Ophthalmol Vis Sci. 2024. PMID: 39636723 Free PMC article.
-
Characterization of intermediate-sized insertions using whole-genome sequencing data and analysis of their functional impact on gene expression.Hum Genet. 2021 Aug;140(8):1201-1216. doi: 10.1007/s00439-021-02291-2. Epub 2021 May 12. Hum Genet. 2021. PMID: 33978893
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous